Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
2,13 USD | +3,90% | +5,45% | -36,61% |
Attività
Numero di dipendenti: 330
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Cell and Gene Therapies
100,0
%
| 130 | 100,0 % | 65 | 100,0 % | -50,42% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 130 | 100,0 % | 65 | 100,0 % | -50,42% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Kristin Yarema
CEO | Chief Executive Officer | 53 | 01/04/23 |
Johanna Mylet
DFI | Director of Finance/CFO | 37 | 01/06/15 |
Mark Gergen
CHM | Chairman | 61 | 01/02/18 |
Loren Wagner
COO | Chief Operating Officer | - | 01/03/21 |
Chief Tech/Sci/R&D Officer | - | - | |
Kristin Martin
ADM | Chief Administrative Officer | 49 | 01/01/19 |
Harry Leonhardt
CMP | Compliance Officer | 67 | 16/07/20 |
Sarah Thailing
IRO | Public Communications Contact | - | 01/11/20 |
Lisa Portale
LAW | General Counsel | - | 01/01/19 |
Karen Basbaum
PRN | Corporate Officer/Principal | - | 01/07/20 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Marcea Lloyd
BRD | Director/Board Member | 75 | 01/01/19 |
Cynthia Collins
BRD | Director/Board Member | 65 | 23/07/21 |
Mark Gergen
CHM | Chairman | 61 | 01/02/18 |
John Schmid
BRD | Director/Board Member | 60 | 19/07/18 |
Charles Baum
BRD | Director/Board Member | 65 | 16/05/22 |
Rafael Amado
BRD | Director/Board Member | 60 | 13/04/23 |
Kristin Yarema
CEO | Chief Executive Officer | 53 | 01/04/23 |
Luke Corning
BRD | Director/Board Member | 41 | 16/12/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 96 489 127 | 63 182 205 ( 65,48 %) | 0 | 65,48 % |
Coordinate società
Poseida Therapeutics, Inc.
9390 Towne Centre Drive Suite 200
92121, San Diego
+858 779 3100
http://www.poseida.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-36,61% | 206 Mln | |
-2,31% | 103 Mrd | |
+0,56% | 95,28 Mrd | |
+1,69% | 22,15 Mrd | |
-17,37% | 21,02 Mrd | |
-9,30% | 18,15 Mrd | |
-41,01% | 16,74 Mrd | |
-14,85% | 16,05 Mrd | |
+3,21% | 13,68 Mrd | |
+33,54% | 12,17 Mrd |
- Borsa valori
- Azioni
- Azione PSTX
- Società Poseida Therapeutics, Inc.